Page last updated: 2024-10-31

mianserin and Hemorrhage

mianserin has been researched along with Hemorrhage in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

ExcerptRelevanceReference
"To report a case of warfarinization involving a patient who developed nasal bleeding and an elevated prothrombin time-international normalized ratio (PT-INR) after taking 15 mg of mirtazapine."3.81[A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy]. ( Kawakami, M; Nishimura, H, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimura, H1
Kawakami, M1
Al-Adwani, A1

Other Studies

2 other studies available for mianserin and Hemorrhage

ArticleYear
[A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2015, Volume: 117, Issue:10

    Topics: Aged; Anticoagulants; Drug Interactions; Hemorrhage; Humans; Male; Mianserin; Mirtazapine; Prothromb

2015
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:13

    Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resist

2005